Risk of lymphoma after renal transplantation varies with time: An analysis of the United States Renal Data System

Transplantation

Volumn 81, Issue 2, 2006, Pages 175-180

  Smith, Jodi M ^a,f   Rudser, Kyle ^b   Gillen, Daniel ^c   Kestenbaum, Bryan ^a   Seliger, Steven ^d   Weiss, Noel ^b   McDonald, Ruth A ^a   Davis, Connie L ^a   Stehmen Breen, Catherine ^b,e  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Ringgold Standard Institution Informatics   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e AMGEN INC   (United States)

^f SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

Lymphoma; Renal; Transplant

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE ANTIBODY; OKT 3; TSUKUBAENOLIDE;

ADULT; AFRICAN AMERICAN; ARTICLE; CANCER INCIDENCE; CANCER RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFORMATION PROCESSING; KIDNEY FAILURE; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; PRIORITY JOURNAL; RISK ASSESSMENT; SURVIVAL; UNITED STATES; CHRONIC KIDNEY FAILURE; FACTUAL DATABASE; HOSPITAL ADMISSION; MIDDLE AGED; RISK FACTOR; TIME;

ADULT; DATABASES, FACTUAL; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LYMPHOMA; MALE; MIDDLE AGED; RISK FACTORS; TIME FACTORS; UNITED STATES; WAITING LISTS;

EID: 33644853668     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000188687.18972.a8     Document Type: Article

References (26)

1. Penn I. The changing pattern of posttransplant malignancies. Transplant Proc 1991; 23: 1101.
2. Ho M, Jaffe R, Miller G, et al. The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children. Transplantation 1988; 45: 719.
3. Cockfield SM, Preiksaitis JK, Jewell LD, et al. Post-transplant lymphoproliferative disorder in renal allograft recipients: clinical experience and risk factor analysis in a single center. Transplantation 1993; 56: 88-96.
4. Walker RC, Paya CV, Marshall WF, et al. Pre-transplantation seronegative Epstein-Barr virus status is the primary risk factor tor post-transplant lymphoproliferative disorder in adult heart, lung, and other solid organ transplantation. J Heart Lung Transplant 1995; 12: 214-221.
5. Walker RC, Marshall WF, Strickler JG, et al. Pretransplantation assessment of the risk of lymphoproliferative disorder. Clin Infect Dis 1995; 20: 1346-1353.
6. Ho M, Miller G, Atchison RW. Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection. J Infect Dis 1985; 152: 876-886.
7. Katz BZ, Raab-Traub N, Miller G. Latent and replicating forms of Epstein-Barr virus DNA in lymphomas and lymphoproliferative diseases. J Infect Dis 1989; 160: 589-598.
8. Ho M, Miller G, Atchison RW. Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection. J Infect Dis 1985; 152: 876-886.
9. Rea D, Fourcade C, Leblond V, et al. Patterns of Epstein-Barr virus latent and replicative gene expression in Epstein-Barr virus B cell lymphoproliferative disorders after organ transplantation. Transplantation 1994; 58: 317-324.
10. Ambinder RF, Mann RB. Detection and characterization of Epstein-Barr virus in clinical specimens. Am J Pathol 1994; 145: 239-252.
11. Patton DF, Wilkowski CW, Hanson CA, et al. Epstein-Barr virus -determined clonality in posttransplant lymphoproliferative disease. Transplantation 1990; 49: 1080-1084.
12. Dharnidharka VR, Tejani AH, Ho PL, Harmon WE. Post-transplant lymphoproliferative disorder in the United States: young Caucasian males are at highest risk. Am J Transplant. 2002; 2: 993-998.
13. Dharnidharka VR, Sullivan EK, Stablein DM, et al. Risk factors for posttransplant lymphoproliferative disorder (PTLD) in pediatric kidney transplantation: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Transplantation 2001; 71 (8): 1065-1068.
14. Lucas KG, Burton RL, Zimmerman SE, et al. Semiquantitative Epstein-Barr virus (EBV) polymerase chain reaction for the determination of patients at risk for EBV-induced lymphoproliferative disease after stem cell transplantation. Blood 1998; 91(10): 3654-3661.
15. Savoie A, Perpete C, Carpentier L, et al. Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative disease. Blood 1994; 83(9): 2715-2722.
16. Rowe DT, Qu L, Reyes J, et al. Use of quantitative competitive PCR to measure Epstein-Barr Virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders. J Clin Microbiol 1997; 35: 1612-1615.
17. Riddler SA, Breinig MC, McKnight JL. Increased levels of circulating Epstein-Barr virus (EBV)-intected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients. Blood 1994; 84(3): 972-984.
18. Green M, Bueno J, Rowe D, et al. Predictive negative value of persistent low Epstein-Barr virus viral load after intestinal transplantation in children. Transplantation 2000; 70(4): 593-596.
19. McDiarmid SV, Jordan S, Kim GS, et al. Prevention and preemptive therapy of postransplant lymphoproliferative disease in pediatric liver recipients. Transplantation 1998; 66(12): 1604-1611.
20. Kenagy DN, Schlesinger Y, Weck K, et al. Epstein-Barr virus DNA in peripheral blood leukocytes of patients with posttransplant lymphoproliferative disease. Transplantation 1995; 60: 547-554.
21. Rooney CM, Loftin SK, Holladay MS, et al. Early identification of Epstein-Barr virus-associated post-transplantation lymphoproliferative disease. Br J Haematology 1995; 89: 98-103.
22. Opelz G, Schwarz V, Henderson R, et al. Non-Hodgkin's lymphoma after kidney or heart transplantation: frequency of occurrence during the first posttransplant year. Transpl Int 1994; 7 Suppl 1: S353-S356.
23. Opelz G, Dohler B. Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transplant 2004; 4(2): 222-230.
24. Heath CW Jr., Brodsky AL, Potolsky AI. Infectious mononucleosis in a general population. Am J Epidemiol 1972; 95(1): 46-52.
25. Tamir D, Benderly A, Levy J, et al. Infectious mononucleosis and Epstein-Barr virus in childhood. Pediatrics 1974; 53(3): 330-335.
26. Henle G, Henle W. Observations on childhood infections with the Epstein-Barr virus. J Infect Dis 1970; 121(3): 303-310.